Exhibit (e)(12)
NONCOMPETE AGREEMENT
This NONCOMPETE AGREEMENT (this “Agreement”), dated as of May 14, 2014 is between Array BioPharma Inc., a Delaware corporation (the “Company”), which for the purposes hereof shall include any subsidiary or affiliate of the Company, and Nicholas Saccamano (the “Employee”).
RECITALS
A. Employee is or may be employed in an executive, management or professional capacity for the Company.
B. The Employee desires to enter into or continue in the employment (as the case may be) of the Company.
C. In order to protect the trade secrets and confidential information of the Company and as a condition to employment or the continued employment (as the case may be) of Employee, the Company requires that Employee enter into this Agreement.
NOW THEREFORE, in consideration of Employee’s employment with the Company and of the mutual covenants and agreements contained herein and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereto agree as follows:
AGREEMENT
1.Covenants Not to Compete or Interfere.
(a) During the term of Employee’s employment with the Company and for a period of 12 months thereafter, and regardless of the reason for Employee’s termination, Employee shall not, within the United States or within a 50 mile radius of any area where the Company is doing business (including any point of sale of the Company’s products or services) at the time of such termination, directly or indirectly own, manage, operate, control, be employed by, serve as a consultant to or otherwise participate in any business that has services or products competitive with those of the Company, or develop products or services competitive with those of the Company (a “Competitive Business”). For purposes of this Agreement, the Company’s business shall be defined as the manufacturing, development and commercialization of small molecule, targeted pharmaceutical products and services for use in the treatment of inflammation and/or cancer; provided, however that a Competitive Business shall only include products for which the Company has substantial development and commercialization rights.